What Do the European Breast Cancer Screening Guidelines Portend for U.S. Practice?
Authors: Joann G. Elmore, Christoph I. Lee
Journal: Annals of Internal Medicine (2019)

Editorials7 January 2020What Do the European Breast Cancer Screening Guidelines Portend for U.S. Practice?Joann G. Elmore, MD, MPH and Christoph I. Lee, MD, MSJoann G. Elmore, MD, MPHDavid Geffen School of Medicine, Los Angeles, California (J.G.E.)Search for more papers by this author and Christoph I. Lee, MD, MSUniversity of Washington School of Medicine, Seattle, Washington (C.I.L.)Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/M19-3104 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Women and clinicians are faced with many “guidelines” for breast cancer screening and must sift through a range of diverse recommendations. The European Breast Guidelines, summarized by Schünemann and colleagues (1), are different: They were developed by an international panel of 28 multidisciplinary members who reviewed the quality of evidence on breast cancer screening in the context of European organized screening programs. What do these guidelines mean for women and clinicians in the United States? Although some aspects of the European Breast Guidelines might be less relevant in the United States, given differences in clinical practice, the challenges of supporting ...References1. Schünemann HJ, Lerda D, Quinn C, et al. Breast cancer screening and diagnosis: a synopsis of the European Breast Guidelines. Ann Intern Med. 2020;172:46-56. doi:10.7326/M19-2125 LinkGoogle Scholar2. Qaseem A, Lin JS, Mustafa RA, et al; Clinical Guidelines Committee of the American College of Physicians. Screening for breast cancer in average-risk women: a guidance statement from the American College of Physicians. Ann Intern Med. 2019;170:547-560. [PMID: 30959525]. doi:10.7326/M18-2147 LinkGoogle Scholar3. Oeffinger KC, Fontham ET, Etzioni R, et al; American Cancer Society. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314:1599-614. [PMID: 26501536] doi:10.1001/jama.2015.12783 CrossrefMedlineGoogle Scholar4. Monticciolo DL, Newell MS, Hendrick RE, et al. Breast cancer screening for average-risk women: recommendations from the ACR commission on breast imaging. J Am Coll Radiol. 2017;14:1137-1143. [PMID: 28648873] doi:10.1016/j.jacr.2017.06.001 CrossrefMedlineGoogle Scholar5. Practice bulletin no. 179 summary: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol. 2017;130:241-243. [PMID: 28644328] doi:10.1097/AOG.0000000000002151 CrossrefMedlineGoogle Scholar6. Elmore JG, Nakano CY, Koepsell TD, et al. International variation in screening mammography interpretations in community-based programs. J Natl Cancer Inst. 2003;95:1384-93. [PMID: 13130114] CrossrefMedlineGoogle Scholar7. U.S. Food and Drug Administration. MQSA National Statistics. Accessed at www.fda.gov/Radiation-EmittingProducts/MammographyQualityStandardsActandProgram/FacilityScorecard/ucm113858.htm on 30 September 2019. Google Scholar8. Houssami N, Kirkpatrick-Jones G, Noguchi N, et al. Artificial Intelligence (AI) for the early detection of breast cancer: a scoping review to assess AI's potential in breast screening practice. Expert Rev Med Devices. 2019;16:351-362. [PMID: 30999781] doi:10.1080/17434440.2019.1610387 CrossrefMedlineGoogle Scholar9. Fenton JJ, Taplin SH, Carney PA, et al. Influence of computer-aided detection on performance of screening mammography. N Engl J Med. 2007;356:1399-409. [PMID: 17409321] CrossrefMedlineGoogle Scholar10. Miglioretti DL, Smith-Bindman R, Abraham L, et al. Radiologist characteristics associated with interpretive performance of diagnostic mammography. J Natl Cancer Inst. 2007;99:1854-63. [PMID: 18073379] CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: David Geffen School of Medicine, Los Angeles, California (J.G.E.)University of Washington School of Medicine, Seattle, Washington (C.I.L.)Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M19-3104.Corresponding Author: Joann G. Elmore, MD, MPH, Department of Medicine, David Geffen School of Medicine at UCLA, 1100 Glendon Avenue, Suite 900, Los Angeles, CA 90024; e-mail, [email protected]ucla.edu.Current Author Addresses: Dr. Elmore: Department of Medicine, David Geffen School of Medicine at UCLA, 1100 Glendon Avenue, Suite 900, Los Angeles, CA 90024.Dr. Lee: Department of Radiology, University of Washington School of Medicine, 1144 Eastlake Avenue East, LG-212, Seattle, WA 98109.This article was published at Annals.org on 26 November 2019. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoBreast Cancer Screening and Diagnosis: A Synopsis of the European Breast Guidelines Holger J. Schünemann , Donata Lerda , Cecily Quinn , Markus Follmann , Pablo Alonso-Coello , Paolo Giorgi Rossi , Annette Lebeau , Lennarth Nyström , Mireille Broeders , Lydia Ioannidou-Mouzaka , Stephen W. Duffy , Bettina Borisch , Patricia Fitzpatrick , Solveig Hofvind , Xavier Castells , Livia Giordano , Carlos Canelo-Aybar , Sue Warman , Robert Mansel , Francesco Sardanelli , Elena Parmelli , Axel Gräwingholt , Zuleika Saz-Parkinson , and Metrics 7 January 2020Volume 172, Issue 1Page: 65-66KeywordsBreast cancer screeningDiagnostic imagingDiagnostic radiologyDisclosureHealth insuranceMagnetic resonance imagingMammographyScreening guidelinesTreatment guidelinesUltrasound imaging ePublished: 26 November 2019 Issue Published: 7 January 2020 Copyright & PermissionsCopyright © 2019 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...